Robex Resources gets court approval for Predictive Discovery merger
Robex Resources (ASX:RXR) has obtained final approval from the Québec Superior Court for its previously announced plan of arrangement with Predictive Discovery (ASX:PDI).

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Robex Resources (ASX:RXR) has obtained final approval from the Québec Superior Court for its previously announced plan of arrangement with Predictive Discovery (ASX:PDI).
Summit Minerals (ASX:SUM) has commenced a low-altitude aeromagnetic survey at its newly acquired Keystone Project in northern Nevada.
Job vacancies in Australia fell slightly by 0.2% in the three months to November 2025, according to new quarterly figures released by the Australian Bureau of Statistics.
HighCom (ASX:HCL) has provided an update on its first-half trading for FY26, with revenue expected between $10.5 million and $11 million and an EBITDA loss of $5 million to $5.8 million.
BlueScope Steel (ASX:BSL) will return $438 million in surplus cash to shareholders through an unfranked special dividend of $1 per share.
Energous Corporation (NASDAQ:WATT), a pioneer in over-the-air (OTA) wireless power networks, announced preliminary results for fiscal year 2025 on Tuesday, highlighting a dramatic expansion in commercial adoption.
AstraZeneca (NASDAQ:AZN) announced Tuesday at the J.P. Morgan Healthcare Conference that it has acquired Boston-based Modella AI, marking the first time a major pharmaceutical company has fully absorbed a specialized artificial intelligence firm.
Payments terminal provider Ingenico has partnered with WalletConnect Pay to enable in-store stablecoin payments across its point-of-sale systems.
NeuroPace (NASDAQ:NPCE) crossed a major financial threshold in 2025, reporting preliminary full-year revenue of approximately $100 million as its brain-responsive neurostimulation technology gains traction as a standard of care for drug-resistant epilepsy.
Cardinal Health (NYSE:CAH) raised its fiscal year 2026 earnings outlook Tuesday, citing rapid acceleration in its specialty pharmaceutical business and a successful navigating of federal drug pricing changes.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy